Clinical Trial Update: Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating anlotinib as maintenance therapy for extensive-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Third Military Medical University | Conditions: Extensive-stage Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN